# A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression

> **NCT07096791** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Chengdu Kanghong Pharmaceutical Group Co., Ltd.** · enrollment: 72 (estimated)

## Conditions studied

- Postpartum Depressive Disorder

## Interventions

- **DRUG:** KH607 tablet
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT07096791
- **Lead sponsor:** Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2027-01
- **Final completion:** 2027-04
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07096791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07096791, "A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07096791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*